Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Glucagen Hypokit
Active Ingredient: Glucagon hydrochloride 1mg
Dosage Form: Powder for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Statens Serum Institut, Copenhagen, Denmark
Novo Nordisk A/S, Gentofte, Denmark
Dated this 4th day of April 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).